A study analyzed Reddit posts to investigate how psilocybin affects self-perception and recognition in mirror gazing, finding it tends to enhances positive self-perception without impairing self-recognition.
Recent psychedelic research shows promising results for mental illnesses and eating disorders, with surveys and reports indicating psilocybin-assisted therapy's potential. However, challenges in research methodology, patient safety concerns, and the need for cautious optimism highlight the gap between scientific evidence...
Socially anxious individuals drink more in the presence of strangers, a study using smartphone surveys and alcohol sensors reveals. Familiarity in social settings inversely affects their alcohol consumption.
A study in Brazil examines the spiritual well-being of psychedelic users and non-users, revealing distinct experiences and emphasizing the need for inclusive spirituality assessment tools.
Doxycycline, an antibiotic, shows promise in reducing addictive effects of drugs like morphine and cocaine, offering new treatment avenues for substance use disorders. These findings, though preliminary and based on male mice, suggest potential for more effective interventions against addiction.
Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.
Despite high hopes, a recent study reveals that a 300mg dose of cannabidiol fails to alleviate cognitive anxiety symptoms, challenging its perceived anxiolytic benefits and prompting a reevaluation of its therapeutic potential. The study was published in Psychopharmacology.
A new study shows how depression alters brain connectivity, particularly in the habenula, and how ketamine treatment reverses these changes. This research enhances understanding of depression and ketamine's rapid antidepressant effects.
New research published in Scientific Reports provides insights into the long-term negative psychological effects of psychedelic drugs. The study helps to identify potential risk factors for persistent anxiety, panic, and other psychological issues following the use of substances such as...
Researchers have discovered significant differences in white matter between regular cannabis users and non-users, indicating potential impacts on brain function. The findings highlight the need for further investigation into cannabis's effects on neurodevelopment.
Scientists at Enveric Biosciences have created novel psilocybin derivatives, potentially offering therapeutic mental health benefits with reduced psychedelic effects. This research paves the way for new treatments for depression and anxiety.
Research from Toronto Western Hospital shows psilocybin-assisted psychotherapy as a promising treatment for major depression and cancer-related distress, calling for urgent advanced clinical trials. This innovative approach combines psychedelic mushrooms with guided therapy, offering new hope in mental health.
Recent research reveals how brain circuits respond differently to drug delivery methods, with rapid dopamine increases significantly impacting addiction-related neural pathways. The study offers new insights into addiction treatment strategies.
New research suggests a single dose of psilocybin, combined with psychotherapy, could significantly reduce depression in individuals with bipolar II disorder, maintaining these effects for 12 weeks. This innovative approach, contrasting sharply with self-medication, highlights the potential of controlled psychedelic...
A new study shows that chronic ketamine exposure causes major changes in mice brains, particularly in the dopamine system, which is crucial for mood and motivation. The study, published in Cell Reports, highlights ketamine's complex effects on brain regions, indicating...